These pooled data help contextualize a prior meta-analysis in 2022 by Yang et al 35 of only patients with HFpEF in which numerical values of KCCQ-12 score improvement were similar but did not reach statistical significance.
← all excerpts
SGLT2 Inhibitors, Functional Capacity, and Quality of Life in Patients With Heart Failure: A Systematic Review and Meta-Analysis.
1
—
—